Title |
Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
|
---|---|
Published in |
Frontiers in immunology, January 2013
|
DOI | 10.3389/fimmu.2013.00354 |
Pubmed ID | |
Authors |
Seleeke Flingai, Matias Czerwonko, Jonathan Goodman, Sagar B. Kudchodkar, Kar Muthumani, David B. Weiner |
Abstract |
In recent years, DNA vaccines have undergone a number of technological advancements that have incited renewed interest and heightened promise in the field. Two such improvements are the use of genetically engineered cytokine adjuvants and plasmid delivery via in vivo electroporation (EP), the latter of which has been shown to increase antigen delivery by nearly 1000-fold compared to naked DNA plasmid delivery alone. Both strategies, either separately or in combination, have been shown to augment cellular and humoral immune responses in not only mice, but also in large animal models. These promising results, coupled with recent clinical trials that have shown enhanced immune responses in humans, highlight the bright prospects for DNA vaccines to address many human diseases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 15% |
United States | 2 | 15% |
United Kingdom | 1 | 8% |
Unknown | 8 | 62% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 85% |
Practitioners (doctors, other healthcare professionals) | 2 | 15% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Sweden | 1 | <1% |
Denmark | 1 | <1% |
Unknown | 160 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 26 | 16% |
Student > Ph. D. Student | 25 | 15% |
Student > Master | 22 | 14% |
Student > Bachelor | 17 | 10% |
Student > Doctoral Student | 8 | 5% |
Other | 21 | 13% |
Unknown | 43 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 33 | 20% |
Biochemistry, Genetics and Molecular Biology | 28 | 17% |
Immunology and Microbiology | 19 | 12% |
Medicine and Dentistry | 11 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
Other | 18 | 11% |
Unknown | 46 | 28% |